spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  stroke 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2024
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Sep 2024
Stryker Completes Acquisition of NICO Corporation, Expanding Minimally Invasive Solutions for Brain Tumor Removal and Stroke Care
Devices Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2024
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash(TM) 2.0 and Lightning Bolt(TM) 7 - in Europe
Devices Interventional Regulatory
 HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Devices Interventional Product Launch
 HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 May 2024
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
Devices Interventional Neurology FDA
 HSMN NewsFeed - 26 Mar 2024
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 12 Mar 2024
Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner(R) Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Jan 2024
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 16 Oct 2023
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Devices Interventional Reimbursement
 HSMN NewsFeed - 4 Aug 2023
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Devices Cardiology FDA
 HSMN NewsFeed - 6 Jul 2023
Append Medical Raises $4.35M in Initial Closing of Extended Series A Round
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 1 Jun 2023
NeuroTrauma Sciences Commences First-in-Human Dosing in the US of Investigational Neuroprotective Drug NTS-104
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 19 May 2023
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 Apr 2023
Reach Neuro Receives FDA Breakthrough Device Designation for Device to Restore Arm and Hand Movement to Chronic Stroke Patients
Devices Neurology FDA
 HSMN NewsFeed - 6 Apr 2023
Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)
Devices Cardiology FDA
 HSMN NewsFeed - 28 Mar 2023
CereVasc Appoints Dr. Adel Malek Chief Medical Officer
Devices Neurosurgery Personnel
 HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Jan 2023
MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim
Devices Neurology Reimbursement
 HSMN NewsFeed - 27 Jan 2023
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 23 Jan 2023
Cadrenal Therapeutics (Nasdaq: CVKD) Granted FDA Fast Track Designation for Tecarfarin for Prevention of Systemic Thromboembolism of Cardiac Origin in Patients with End-Stage Renal Disease and Atrial Fibrillation
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Jan 2023
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
Devices Venture Capital
 HSMN NewsFeed - 22 Dec 2022
ITC Rules Apple Violated AliveCor's Patents
Devices Cardiology Litigation
 HSMN NewsFeed - 15 Dec 2022
CardiaCare Announces Licensing and Distribution Agreement to Commercialize its Digital Neuromodulation Wearable for Non-invasive Atrial Fibrillation Treatment
Devices Cardiology Distribution
 HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 26 Oct 2022
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife(R) System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
Devices Reimbursement
 HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Oct 2022
Phagenesis Launches Phagenyx Neurostimulation System in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 23 Sep 2022
iSyncWave EEG Scanner Receives FDA 510k Clearance
Devices Neurology FDA
 HSMN NewsFeed - 13 Sep 2022
RapidPulse Raises Additional Funding for Ischemic Stroke Therapies and Notes Promising Results
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 17 Aug 2022
CathVision Announces Close Of $7.2 Million Financing Round
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 13 Jul 2022
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study
Devices
 HSMN NewsFeed - 11 Jul 2022
Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jun 2022
MicroTransponder Raises $53M, Appoints New CEO
Devices Neurology Personnel Venture Capital
 HSMN NewsFeed - 17 Jun 2022
Conformal Medical Announces Launch of CONFORM Pivotal Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 17 May 2022
EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2022
Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)
Devices Interventional
 HSMN NewsFeed - 28 Apr 2022
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer(TM) Steerable Delivery Sheath for the Company's Amulet(TM) Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Devices Interventional Acquisitions
 HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2022
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi(R) (solriamfetol) to Axsome Therapeutics
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 24 Feb 2022
Artio Medical Welcomes New R&D Leaders and Accelerates Development of Amplifi(TM) Vein Dilation System
Devices Personnel
 HSMN NewsFeed - 8 Feb 2022
FDA Approves JUVÉDERM(R) VOLBELLA(R) XC for Undereye Hollows
Devices Dermatology FDA
 HSMN NewsFeed - 1 Feb 2022
FDA Clears World's First Credit-Card-Sized Personal ECG
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 12 Jan 2022
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Jan 2022
AliveCor Announces Strategic Additions to Executive Team
Devices Monitoring Personnel
 HSMN NewsFeed - 10 Jan 2022
Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease
Devices Cardiology
 HSMN NewsFeed - 7 Jan 2022
NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
Devices Monitoring Cardiology
 HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2021
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Devices Interventional Regulatory
 HSMN NewsFeed - 14 Sep 2021
Jupiter Orphan Therapeutics, Inc. Announces New Corporate Name, Jupiter Neurosciences, Inc.
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Sep 2021
CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR(TM) Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Devices Surgery FDA
 HSMN NewsFeed - 31 Aug 2021
MicroTransponder(R) Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors
Devices Neurology FDA
 HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 16 Aug 2021
Abbott's Amplatzer(TM) Amulet(TM) Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Aug 2021
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 12 Aug 2021
Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR(TM) Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
Devices FDA
 HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch
 HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 29 Jun 2021
CardioFocus Appoints Stephan Ogilvie as Chief Financial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 25 Jun 2021
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jun 2021
Veralox Therapeutics Appoints Michael Hanna As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jun 2021
Medtronic to Stop Distribution and Sale of HVAD(TM) System
Devices Cardiology Distribution
 HSMN NewsFeed - 3 Jun 2021
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jun 2021
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China
Devices Interventional Cardiology Licensing
 HSMN NewsFeed - 28 May 2021
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 27 May 2021
FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA(TM)-T Percutaneous Tricuspid Annuloplasty System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 18 May 2021
Late-Breaking Registry Data at EuroPCR Congress Demonstrate Reduced Paravalvular Leak and Low Permanent Pacemaker Rates for the ACURATE neo2(TM) Aortic Valve System
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2021
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 May 2021
Galaxy Medical and Japan Lifeline Enter Distribution Agreement For Novel Pulsed Electric Field Focal Ablation Catheter
Devices Cardiology Distribution
 HSMN NewsFeed - 26 Apr 2021
Phoenix Cardiac Receives CE Mark for its Innovative BACE Device to Treat Functional Mitral Regurgitation
Devices Cardiology Regulatory
 HSMN NewsFeed - 1 Apr 2021
SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 3 Mar 2021
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
Regenerative Medicine FDA
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2021
SpinTech Acquires MR Innovations
Devices Radiology Neurology Mergers & Acquisitions
 HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Devices Dermatology FDA
 HSMN NewsFeed - 29 Jan 2021
FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 21 Jan 2021
MIVI Neuroscience Secures Series B Funding
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 24 Nov 2020
Signifier Medical Technologies appoints Alastair Maxwell as Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 24 Nov 2020
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
Devices Cardiology Monitoring Venture Capital
 HSMN NewsFeed - 23 Nov 2020
Rapid Medical Expands Comaneci(TM) CE Mark Indication to Include Vasospasm Treatment
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 23 Nov 2020
FDA Clears First of its Kind Algorithm Suite for Personal ECG
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 10 Nov 2020
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
Devices
 HSMN NewsFeed - 3 Nov 2020
FDA Approves Updated Label for Endari(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2020
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2020
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2020
Signifier Medical Technologies appoints Travis Nieman as Managing Director International
Devices Personnel
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Sep 2020
Boston Scientific Launches ACURATE neo2(TM) Aortic Valve System in Europe
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital
 HSMN NewsFeed - 2 Sep 2020
Letter from Seneca Biopharma's Executive Chairman
Biopharmaceuticals
 HSMN NewsFeed - 11 Aug 2020
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 4 Aug 2020
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2020
Stryker's Neuroform Atlas(R) Stent System granted an expanded indication, providing a new option for patients with aneurysms in the back of the brain
Devices Interventional Neurology FDA
 HSMN NewsFeed - 27 Jul 2020
Rapid Medical Receives CE Mark for TIGERTRIEVER(TM) XL
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 22 Jul 2020
Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jun 2020
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 22 Jun 2020
FDA Accepts Supplemental Biologics License Application (sBLA) for BOTOX(R) (onabotulinumtoxinA) for the Treatment of Pediatric Patients with Neurogenic Detrusor Overactivity
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 14 May 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa(R) for Third Year
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 8 May 2020
FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 May 2020
FDA Clears New Mechanical Thrombectomy Platform
Devices Interventional FDA
 HSMN NewsFeed - 5 May 2020
Galderma Receives FDA Approval For Restylane(R) Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth
Devices Dermatology FDA
 HSMN NewsFeed - 5 May 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 9 Apr 2020
EMD Serono and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Apr 2020
Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 7 Apr 2020
Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device
Devices Interventional Radiology Neurology
 HSMN NewsFeed - 30 Mar 2020
MIVI Neuroscience Promotes Bob Colloton to CEO and Appoints Robert Stern to Board of Directors
Devices Interventional Radiology Personnel
 HSMN NewsFeed - 17 Mar 2020
Artio Medical Announces Interim Study Results Highlighting Aneurysm Occlusion Device at Neurovascular Conference
Devices Neurology Interventional
 HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2020
TriGUARD 3(TM) Cerebral Embolic Protection Device Receives CE Mark for Use in Transcatheter Heart Procedures
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Mar 2020
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Mar 2020
New Data Demonstrates Andexxa(R) Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Biopharmaceuticals
 HSMN NewsFeed - 29 Jan 2020
CytoSorb(R) is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Devices Regulatory Product Launch
 HSMN NewsFeed - 29 Jan 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jan 2020
Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Jan 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 2 Jan 2020
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Dec 2019
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Dec 2019
Prasco launches NuvaRing(R) (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 16 Dec 2019
IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care
Devices Neurosurgery Monitoring Product Launch
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 20 Nov 2019
First Cryoballoon Ablation Procedures Performed Using the VersaCross(R) Transseptal Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Nov 2019
Aruvant Appoints William Chou as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2019
Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Nov 2019
CytoSorbents Enrolls First Patient in TISORB Trial and Opens Operating Subsidiary in the United Kingdom
Devices
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 21 Oct 2019
Perflow Medical Receives CE Mark Approval of Novel Cascade(TM) Agile
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 18 Oct 2019
EVENITY(R) (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Oct 2019
FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Devices FDA
 HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 24 Sep 2019
Emmaus Life Sciences Reinforces Positive Outcomes of Endari(R) Clinical Trials, Including Efficacy Findings That Led to FDA Approval
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 18 Sep 2019
Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Biopharmaceuticals Devices Dermatology FDA
 HSMN NewsFeed - 28 Aug 2019
Harmonic Bionics Announces Appointment of Christopher Prentice as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 27 Aug 2019
EBR Systems Closes $30M in New Funding, John McCutcheon Joins Company as President and CEO
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA
 HSMN NewsFeed - 7 Aug 2019
Glycomine, Inc. Announces $33 Million Series B Financing to Advance its Therapy for a Congenital Disease of Glycosylation
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Aug 2019
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) THIN LIQUID (barium sulfate) for oral suspension
Biopharmaceuticals Radiology Gastroenterology FDA
 HSMN NewsFeed - 25 Jul 2019
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator(R) Device for Non-Invasive Treatment of Spasticity
Devices Neurology
 HSMN NewsFeed - 22 Jul 2019
Zynex Expands Executive Team, Appoints Joseph Papandrea Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 18 Jul 2019
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Jul 2019
Q'Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter
Devices Interventional FDA
 HSMN NewsFeed - 8 Jul 2019
BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2019
GORE(R) CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
Devices Regulatory
 HSMN NewsFeed - 22 May 2019
Edwards Announces Milestones For Transcatheter Mitral Program
Devices Cardiology Interventional
 HSMN NewsFeed - 13 May 2019
FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 8 May 2019
ReNeuron Provides Business Update and Results Notification
Regenerative Medicine Ophthalmology Neurology
 HSMN NewsFeed - 7 May 2019
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
Devices Interventional FDA
 HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 23 Apr 2019
FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Mar 2019
RegeneRx Announces New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2019
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
Biopharmaceuticals FDA Regulatory
 HSMN NewsFeed - 14 Mar 2019
FDA Approves New Indication for Valve Repair Device to Treat Certain Heart Failure Patients with Mitral Regurgitation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 13 Mar 2019
Boston Scientific Receives CE Mark for Next Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2019
Zynex names new Vice President of Sales and Marketing
Devices Neurology Personnel
 HSMN NewsFeed - 26 Feb 2019
AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 19 Feb 2019
ReWalk Announces 510k FDA Submission for ReStore(TM) Exo-Suit for Stroke Rehabilitation
Devices FDA
 HSMN NewsFeed - 14 Feb 2019
Boehringer Ingelheim and Lilly announce the CAROLINA(R) cardiovascular outcome trial of Tradjenta(R) met its primary endpoint of non-inferiority compared with glimepiride
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 13 Feb 2019
ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
Devices Reimbursement
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 21 Jan 2019
Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 17 Jan 2019
Johnson & Johnson Announces Research Study with Apple Watch to Help Improve AFib Outcomes Including Stroke Prevention
Devices Cardiology Monitoring
 HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2018
HeartGuide, the highly-anticipated first wearable blood pressure monitor from Omron, available for pre-order on December 20th
Devices Monitoring Product Launch
 HSMN NewsFeed - 19 Dec 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Nov 2018
Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives CE Mark
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Nov 2018
ReWalk Announces Placement of 500th Exoskeleton System
Devices
 HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Devices Dermatology FDA
 HSMN NewsFeed - 30 Oct 2018
U.S. FDA Approves INVOKANA(R) (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Oct 2018
Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2018
Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant
Devices Cardiology FDA
 HSMN NewsFeed - 4 Oct 2018
EPIX Therapeutics Announces Completion of DIAMOND-AF Paroxysmal Study and First Enrollment in DIAMOND-AF II Persistent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Sep 2018
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2018
Livongo Announces First Cellular-Enabled Blood Pressure Monitoring System in U.S.
Devices Cardiology Product Launch
 HSMN NewsFeed - 14 Sep 2018
Endotronix Raises $45 Million in Series D Financing for the Treatment of Heart Failure
Devices Cardiology Venture Capital
 HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 Sep 2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to product/label mix-up
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 3 Sep 2018
Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 31 Aug 2018
FDA announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles
Biopharmaceuticals FDA Product Recall
 HSMN NewsFeed - 31 Aug 2018
CardioVascular BioTherapeutics, Inc. Appoints Dr. David M. Ornitz and Dr. Arnold I. Chin to its Scientific and Medical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Devices Cardiology
 HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals
 HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology
 HSMN NewsFeed - 27 Aug 2018
Janssen Announces Results from MARINER and COMMANDER HF Studies
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Aug 2018
Sotera Medical Secures Additional Funding
Devices Cardiology Venture Capital
 HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 13 Aug 2018
Advanced Cardiac Therapeutics, Inc. Changes Name to EPIX Therapeutics, Inc.
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 Aug 2018
Boston Scientific Closes Acquisition of Claret Medical, Inc., Announces Positive Reimbursement Decision
Devices Interventional Acquisitions Reimbursement
 HSMN NewsFeed - 26 Jul 2018
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Jul 2018
Perflow Medical Announces the First Clinical Use of the Cascade(TM) Dynamic Non-Occlusive Remodeling Net
Devices Interventional Neurology
 HSMN NewsFeed - 20 Jul 2018
Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2018
Stryker receives US FDA Pre-market approval for the Surpass Streamline(TM) Flow Diverter to treat large and giant unruptured aneurysms
Devices Interventional Neurology Radiology FDA
 HSMN NewsFeed - 16 Jul 2018
NeuroTrauma Sciences and Henry Ford Health System Announce Research and License Agreements to Develop Exosome Technology for Neurological Injury
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 16 Jul 2018
Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories, Inc.
Diagnostics Product Launch
 HSMN NewsFeed - 10 Jul 2018
NobleStitch(TM) EL PFO Closure Highlighted at CSI Congress with Prof. Horst Sievert Performing his 100th NobleStitch Case on Opening Day
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jul 2018
Philips Launches the New Sonicare ProtectiveClean Electric Toothbrush Range Offering an Amazingly Effective, yet Gentle Clean
Devices Dental Product Launch
 HSMN NewsFeed - 12 Jun 2018
MicroVention Announces FDA Clearance For Thrombectomy Device
Devices Interventional Neurology FDA
 HSMN NewsFeed - 11 Jun 2018
Bionik Laboratories Appoints Renaud Maloberti as Chief Commercial Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 30 May 2018
FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 23 May 2018
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Devices Interventional Cardiology
 HSMN NewsFeed - 23 May 2018
ReCor Medical Announces RADIANCE-HTN SOLO Hypertension Study Meets Primary Efficacy Endpoint, Pivotal Study Submission, and New Principal Investigator
Devices Cardiology
 HSMN NewsFeed - 22 May 2018
MaxQ-AI Receives CE Mark Approval for Accipio(TM)Ix Intracranial Hemorrhage Artificial Intelligence Software Platform
Devices Radiology Neurology Regulatory
 HSMN NewsFeed - 22 May 2018
Nobles Medical Technologies II Showcases Noblestitch(TM) PFO Closure At EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA
 HSMN NewsFeed - 21 May 2018
Nestlé Skin Health Announces the FDA Approval of Restylane(R) Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
Devices Dermatology FDA
 HSMN NewsFeed - 17 May 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 May 2018
Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 16 May 2018
Bionik Laboratories Announces Rental Agreement with Tallahassee Memorial HealthCare for InMotion Arm Robotic System
Devices
 HSMN NewsFeed - 15 May 2018
BrainQ Technologies Raises $8.8 Million to Treat Neurodisorders With Artificial Intelligence
Devices Neurology Venture Capital
 HSMN NewsFeed - 3 May 2018
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
Devices Cardiology FDA
 HSMN NewsFeed - 2 May 2018
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 23 Apr 2018
Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Devices Interventional FDA
 HSMN NewsFeed - 19 Apr 2018
Emboline, Inc. Completes Funding Of Over $10 Million
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 3 Apr 2018
FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Apr 2018
Brainomix Secures £7m ($9.8m) Investment to Tackle Strokes With AI
Devices Neurology Venture Capital
 HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 26 Mar 2018
Pythagoras Medical Receives CE-Mark for the ConfidenHT(TM) System
Devices Cardiology Regulatory
 HSMN NewsFeed - 26 Mar 2018
Bioness Receives FDA Clearance for myBioness(TM) iOS app for mobile control of the L300 Go(TM) System
Devices FDA
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 20 Mar 2018
Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
Devices Neurology Personnel
 HSMN NewsFeed - 19 Mar 2018
EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 7 Mar 2018
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea
Devices Distribution
 HSMN NewsFeed - 7 Mar 2018
Contego Medical Announces the Start of Enrollment in the PERFORMANCE I Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Feb 2018
Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
Devices Interventional Licensing
 HSMN NewsFeed - 15 Feb 2018
Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 15 Feb 2018
Viz.ai Granted De Novo FDA Clearance for First Artificial Intelligence Triage Software
Devices Radiology Neurology FDA
 HSMN NewsFeed - 15 Feb 2018
Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark
Devices Cardiology Regulatory
 HSMN NewsFeed - 14 Feb 2018
Phase II Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People With Diabetic Macular Edema
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Feb 2018
SanBio and Teijin to Terminate Licensing Agreement regarding SB623 for Stroke Treatment
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 1 Feb 2018
Zynex introduces the NeuroMove(TM) Device to its expanding sales force
Devices Product Launch
 HSMN NewsFeed - 29 Jan 2018
Bionik Laboratories Corp. Appoints Andre Auberton-Herve as Chairman of Board of Directors
Devices Personnel
 HSMN NewsFeed - 29 Jan 2018
MedyMatch Receives Expedited Access Pathway / Breakthrough Device Designation from the FDA to Accelerate Market Access for Intracranial Hemorrhage Software
Devices Radiology Neurosurgery FDA
 HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Jan 2018
New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
Devices Drug Delivery Neurology
 HSMN NewsFeed - 11 Jan 2018
First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2018
Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Dec 2017
Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA(R) (iobenguane I 131) in Pheochromocytoma and Paraganglioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Dec 2017
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace(R) Cream
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Dec 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 Dec 2017
INVOKANA(R) (canagliflozin) Significantly Improved Renal Outcomes and Demonstrated Potential Renal Protective Effects in Patients with Type 2 Diabetes Who Have or Are at Risk for Cardiovascular Disease
Biopharmaceuticals Nephrology
 HSMN NewsFeed - 30 Nov 2017
Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
Biopharmaceuticals Neurology Reimbursement
 HSMN NewsFeed - 30 Nov 2017
FDA Clears First Medical Device Accessory for Apple Watch(R)
Devices Cardiology FDA
 HSMN NewsFeed - 27 Nov 2017
Regeneron Provides Update on EYLEA(R) (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Nov 2017
HeartStitch(R) "Sutures The Future" at the TCT in Denver, Colorado
Devices Cardiology
 HSMN NewsFeed - 15 Nov 2017
Noden Pharma Announces FDA Approval of Tekturna(R) (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 15 Nov 2017
Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs
Devices Cardioloy Venture Capital
 HSMN NewsFeed - 14 Nov 2017
FDA warns about illegal use of injectable silicone for body contouring and associated health risks
Devices Dermatology FDA
 HSMN NewsFeed - 13 Nov 2017
Allergan Receives FDA Approval For Use of VRAYLAR(TM) (cariprazine) in the Maintenance Treatment of Schizophrenia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 9 Nov 2017
Stryker Receives US FDA HDE Approval ror the Neuroform Atlas(TM) Stent System to Treat Wide Neck Aneurysms
Devices Interventional FDA
 HSMN NewsFeed - 7 Nov 2017
Welch Allyn Introduces Connex(R) Cardio ECG
Devices Cardiology Product Launch
 HSMN NewsFeed - 6 Nov 2017
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Oct 2017
Silk Road Medical Appoints World Class Stroke Prevention Champion to Serve as Vice President, Medical Affairs and Professional Education
Devices Neurology Personnel
 HSMN NewsFeed - 2 Oct 2017
Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Sep 2017
Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD
Devices Cardiology FDA
 HSMN NewsFeed - 13 Sep 2017
IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling
Devices Neurology Personnel
 HSMN NewsFeed - 7 Sep 2017
Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business
Devices Neurology Interventional
 HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 30 Aug 2017
IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO
Devices Neurosurgery Monitoring Personnel
 HSMN NewsFeed - 28 Aug 2017
Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients
Devices Cardiology FDA Product Launch
 HSMN NewsFeed - 21 Aug 2017
Cardiome Provides U.S. Regulatory Update For BRINAVESS
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 Aug 2017
HeartSciences Announces CE Mark and European Launch of MyoVista(R) High Sensitivity ECG Device
Devices Diagnostics Cardiology Regulatory Product Launch
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 28 Jul 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for VARIBAR(R) NECTAR (barium sulfate) Oral Suspension
Diagnostics Radiology Gastroenterology FDA
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Jul 2017
Silk Road Medical Announces $47 Million Financing led by Norwest Venture Partners and Funds Managed by Janus Capital Management LLC
Devices Interventional Radiology Venture Capital
 HSMN NewsFeed - 17 Jul 2017
Sensome, Formerly Instent, Raises €4.7m to Bring the World's First Connected Stroke Guidewire to Patients
Devices Interventional Venture Capital
 HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 12 Jun 2017
Cardiome Announces Commercial Launch of BRINAVESS(R) (Vernakalant Hydrochloride) in Canada
Biopharmaceuticals Cardiology Product Launch
 HSMN NewsFeed - 9 Jun 2017
Zynex Hires Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 6 Jun 2017
100,000th Robotic-Arm Assisted Joint Replacement Procedure Performed in the U.S. with Stryker's Mako System
Devices Orthopaedic
 HSMN NewsFeed - 17 May 2017
Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2017
The Boston Scientific LOTUS(TM) Valve System Demonstrated Superior Efficacy to CoreValve(R) in Global REPRISE III Trial at One Year
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2017
Bioness and Ottobock Announce Strategic European Distribution Partnership
Devices Distribution
 HSMN NewsFeed - 5 May 2017
Ram Group Announces Breakthrough in Non-Invasive Cardio-Pulmonary Monitoring Wearables
Devices Cardiology Monitoring
 HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Apr 2017
Venus Medtech's TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In China
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Apr 2017
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
Devices Neurosurgery Product Launch
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2017
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
Devices Neurology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Mar 2017
JUVÉDERM VOLLURE(TM) XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
Devices Dermatology FDA
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Mar 2017
New Study Shows Prevencio’s Simple Blood Test Determines Risk of Heart Attack, Stroke, or Cardiovascular Death
Diagnostics Cardiology
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional
 HSMN NewsFeed - 24 Feb 2017
ANI Pharmaceuticals Acquires Inderal(R) XL and InnoPran XL(R)
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 7 Feb 2017
Bioness Receives FDA Clearance for the L300 Go(TM) System
Devices Orthopaedic FDA
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Jan 2017
FDA Grants Priority Review for Genentech’s Actemra(R) (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 13 Dec 2016
Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy
Regenerative Medicine Neurology
 HSMN NewsFeed - 12 Dec 2016
Galderma Announces FDA Approval of Restylane(R) Refyne and Restylane(R) Defyne Dermal Fillers for Treatment of "Laugh Lines"
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 1 Dec 2016
Akers Biosciences Signs Distribution Agreement with First Check Diagnostics for Rapid Cholesterol Test
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
Hill-Rom Introduces Welch Allyn Home(TM) Hypertension Program
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 21 Nov 2016
Neural Analytics Announces Commercial Launch of Lucid(TM) M1 Transcranial Doppler Ultrasound System at 9th Annual Society of Vascular and Interventional Neurology Meeting
Devices Monitoring Neurology Product Launch
 HSMN NewsFeed - 15 Nov 2016
Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Ill Patients with Extended-Duration Betrixaban
Biopharmaceuticals
 HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 8 Nov 2016
Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant for Contrave(R) (naltrexone HCl / bupropion HCl extended release) in Australia and New Zealand
Biopharmaceuticals Distribution
 HSMN NewsFeed - 4 Nov 2016
CorWave Raises $17.1 Million in Series B Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 1 Nov 2016
Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 28 Oct 2016
AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke
Devices Cardiology
 HSMN NewsFeed - 24 Oct 2016
Efficacy of Ofev(R) (nintedanib) Reinforced in Range of Patients with IPF in New Analyses Presented at CHEST
Biopharmaceuticals
 HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Sep 2016
U.S. FDA Approves INVOKAMET(R) XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 20 Sep 2016
KVK Tech Announces FDA-Approval of Lomaira(TM) (phentermine hydrochloride USP) 8 mg tablets, CIV, A Low-Cost, Low-Dose Phentermine That Can Be Used Up To Three Times Daily for Weight Reduction
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Devices Neurology Interventional Product Launch
 HSMN NewsFeed - 2 Sep 2016
Merck Provides Update on Odanacatib Development Program
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2016
Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4(TM) Study of Factor Xa Inhibitor Antidote AndexXa(TM) (andexanet alfa) in Patients with Acute Major Bleeding
Biopharmaceuticals
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2016
Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Aug 2016
Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) for IndexXa(TM) (andexanet alfa), a Factor Xa Inhibitor Antidote
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Aug 2016
Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa(TM) (andexanet alfa)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Aug 2016
Ornim Raises $20 Million in Latest Equity Financing Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 2 Aug 2016
GORE(R) TIGRIS(R) Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 1 Aug 2016
Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport(R) (Abobotulinumtoxin A) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2016
Micro Interventional Devices, Inc. Receives FDA Market Clearance for Permaseal(TM)
Devices Cardiology Surgery FDA
 HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 29 Jun 2016
FDA Advisory Committee recommends approval of Jardiance(R) (empagliflozin) for cardiovascular indication in 12-11 vote
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Jun 2016
HeartStitch(R) Expanding Products' Clinical Databases Across the Globe
Devices Cardiology
 HSMN NewsFeed - 17 Jun 2016
ARIAD Announces Distribution Agreements for Iclusig(R) in Latin America and the Middle East/North Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 10 Jun 2016
HeartStitch(R) Announces Top New Sales and Marketing VP Joins the HeartStitch Team
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Jun 2016
Zynex Hires Vice President of Operations
Devices Personnel
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 Jun 2016
ARIAD Completes the Sale of Its European Operations and Out-License of European Rights to Iclusig(R)
Biopharmaceuticals Oncology Licensing Acquisitions
 HSMN NewsFeed - 2 Jun 2016
Occlutech Obtains European CE Mark Approval for its LAA Occluder
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 May 2016
Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2016
HeartStitch(R) Announces New Director of Regulatory Affairs and Quality Assurance
Devices Cardiology Personnel
 HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Regenerative Medicine Neurology
 HSMN NewsFeed - 19 May 2016
TriGuard Cerebral Protection Device Shows Reduction in Stroke Rate and Improvement in Patients' Neurological Outcomes in TAVR Procedures
Devices Interventional Cardiology Neurology
 HSMN NewsFeed - 17 May 2016
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2016
Neos Therapeutics Announces U.S. Launch of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients Six Years and Older
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Apr 2016
AbbVie Announces Real-World Data with VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA(R) (dasabuvir tablets) from Large German Hepatitis C-Registry
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2016
AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Apr 2016
Ekso GT(TM) Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients
Devices Neurology FDA
 HSMN NewsFeed - 16 Mar 2016
Allergan Announces U.S. Availability of VRAYLAR(TM) (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Mar 2016
Revolutionary 3D Cardiac Mapping System Developed by Aurora Health Care Physician Receives FDA Clearance
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Feb 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 8 Feb 2016
Boston Scientific Announces Medicare Will Cover WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 3 Feb 2016
Emmaus Life Sciences Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2016
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
Devices Neurology
 HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Jan 2016
Contego Medical Announces Positive Clinical Data for Paladin(R) System, the First Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology
Devices Interventional
 HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Jan 2016
vasopharm Announces EUR 20 Million Fundraising to Progress Treatment for Traumatic Brain Injury
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 15 Jan 2016
Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve
Devices Cardiology FDA
 HSMN NewsFeed - 11 Jan 2016
Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2016
Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2016
Vascular Dynamics’ MobiusHD(TM) System Receives CE Mark for the Treatment of Resistant Hypertension
Devices Cardiology Regulatory
 HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Dec 2015
Cardiorentis' Ularitide Receives FDA Fast Track Designation for the Treatment of Acute Decompensated Heart Failure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 9 Dec 2015
Voluntary Recall of Chariot(TM) Guiding Sheath
Devices Interventional Product Recall
 HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2015
CVRx(R) Announces Expedited Access Pathway Designation By FDA for Barostim Therapy(R) for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients
Devices Cardiology FDA
 HSMN NewsFeed - 11 Nov 2015
AliveCor Announces Appointment of Chief Executive Officer
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 5 Nov 2015
Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke
Devices Neurosurgery Interventional
 HSMN NewsFeed - 30 Oct 2015
Regeneron Announces EU Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 23 Oct 2015
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2015
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
Devices Interventional Venture Capital
 HSMN NewsFeed - 16 Oct 2015
Vittamed secures $10M in venture funding for commercialization of non-invasive Intracranial Pressure (ICP) system
Devices Neurosurgery Monitoring Venture Capital
 HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Oct 2015
U.S. FDA Approves JUVEDERM(R) ULTRA XC for Use in Lips
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 30 Sep 2015
AtriCure Announces Launch of the cryoFORM(TM) Cryoablation Probe
Devices Cardiology Product Launch
 HSMN NewsFeed - 20 Aug 2015
Jardiance(R) Demonstrated Cardiovascular (CV) Risk Reduction in People with Type 2 Diabetes at High Risk for CV Events
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Devices Neurology Product Launch
 HSMN NewsFeed - 10 Aug 2015
FDA Approves Taro’s Keveyis(TM) (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Aug 2015
NICE Recommends Once-daily Lixiana(R) (Edoxaban) for Preventing Stroke and Systemic Embolism in People with Non-valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 4 Aug 2015
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 19 Jun 2015
Sorin Group Announces European Launch of KORA 250, the World’s Smallest Full Body MRI Conditional Pacing System
Devices Cardiology Radiology Product Launch
 HSMN NewsFeed - 17 Jun 2015
Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2015
Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 May 2015
CVRx(R) Barostim Therapy(R) for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference
Devices Cardiology
 HSMN NewsFeed - 19 May 2015
FDA Grants Premarket Approval for Silk Road Medical's ENROUTE(R) Transcarotid Stent System
Devices Interventional FDA
 HSMN NewsFeed - 18 May 2015
Vesiflo Introduces the inFlow Device and Its Companion Patient Monitoring System
Devices Urology Product Launch
 HSMN NewsFeed - 13 May 2015
St. Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in Europe
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 May 2015
OMEICOS Appoints Dr. Ulrich Dauer as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 17 Apr 2015
Global Trials Show Addition of Medtronic’s Solitaire(TM) Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
Devices Interventional Neurology
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Mar 2015
CVRx(R) Barostim Therapy(TM) for Heart Failure Clinical Trial Results Presented in a Featured Clinical Research Session of the American College of Cardiology Annual Conference
Devices Cardiology
 HSMN NewsFeed - 13 Mar 2015
Boston Scientific Receives FDA Approval for WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Cardiology FDA
 HSMN NewsFeed - 13 Mar 2015
Actavis Receives FDA Approval of SAPHRIS(R) for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2015
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 10 Feb 2015
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Devices Interventional FDA
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Jan 2015
Micro Interventional Devices, Inc. Completes STASIS Clinical Trial Enrollment
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jan 2015
Mundipharma receives positive European Commission decision on Targin(R) (oxycodone/naloxone) for the treatment of Restless Legs Syndrome1
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Jan 2015
CardioFocus partners with Japan Lifeline for distribution of the HeartLight Laser Balloon to treat Atrial Fibrillation
Devices Cardiology Distribution
 HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Dec 2014
CVRx(R) Granted Humanitarian Device Exemption Approval from FDA for Barostim neo legacy(TM) Hypertension Therapy Device
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2014
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
Devices Cardiology Regulatory
 HSMN NewsFeed - 9 Dec 2014
Zydus Launches World's First Biosimilar of Adalimumab
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 8 Dec 2014
CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 19 Nov 2014
Argon Medical's CLEANER XT(TM) and CLEANER 15(TM) Rotational Thrombectomy Systems Receive FDA Clearance for Mechanical Declotting and Infusion in the Peripheral Vasculature
Devices Interventional FDA
 HSMN NewsFeed - 11 Nov 2014
St. Mary’s Health Care System Expands Cardiac Imaging with Toshiba MR
Devices Radiology
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 28 Oct 2014
Hanson Medical Systems Becomes Preferred Distributor for PTS Diagnostics' CardioChek Family of Products
Diagnostics Distribution
 HSMN NewsFeed - 17 Oct 2014
EYLEA(R) (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both Bevacizumab and Ranibizumab in NIH-Sponsored Diabetic Macular Edema Study
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 6 Oct 2014
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Sep 2014
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America over SB623, Therapy for Stroke
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Sep 2014
Regeneron Announces EYLEA(R) (aflibercept) Injection Approved for the Treatment of Patients with Myopic Choroidal Neovascularization (CNV) in Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 20 Aug 2014
Advanced Catheter Therapies Announces Series B Equity Financing
Devices Venture Capital
 HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2014
Zynex Announces Brian Alleman as Chief Financial Officer
Devices Neurology Personnel
 HSMN NewsFeed - 15 Jul 2014
Pradaxa(R) (dabigatran etexilate) Now Available in the UK for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and Prevention of Recurrence
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Jun 2014
Eliquis(R) (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2014
Zynex Appoints Director of Business Development
Devices Personnel
 HSMN NewsFeed - 23 Jun 2014
New Philips NeuroSuite Reveals the Brain's Vascular Network like Never Before
Devices Neurology Interventional Radiology
 HSMN NewsFeed - 5 Jun 2014
QT Vascular Announces FDA Clearance of Chocolate PTCA Balloon Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 2 Jun 2014
Toshiba’s Aquilion ONE Family Puts Customers First with the Industry’s Only Scalable Premium CT Solution
Devices Radiology Product Launch
 HSMN NewsFeed - 22 May 2014
Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology
Devices Interventional
 HSMN NewsFeed - 22 May 2014
Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective
Devices Cardiology
 HSMN NewsFeed - 22 May 2014
Primary Endpoint Data Presented on Performance and Safety of the JenaValve TAVI System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2014
El Camino Hospital Installs Five Carestream DRX Imaging Systems to Perform Portable X-ray Exams at Two Campuses
Devices Radiology
 HSMN NewsFeed - 20 May 2014
InspireMD to Showcase Embolic Systems with MicroNet(TM) Technology and Results from MASTER I Trial at EuroPCR Conference
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2014
GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss
Devices Neurology Radiology Distribution
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 1 May 2014
FDA Approves Inspire(R) Upper Airway Stimulation (UAS) Therapy for Obstructive Sleep Apnea
Devices FDA
 HSMN NewsFeed - 1 May 2014
BOTOX(R) (Botulinum Toxin Type A) Receives a Positive Opinion in Fourteen European Countries for the Treatment of Focal Spasticity of the Ankle in Adult Post Stroke Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Apr 2014
Abbott's First-of-Its-Kind MitraClip(R) Device Now Approved in Canada
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions
 HSMN NewsFeed - 11 Apr 2014
Covidien Implements Voluntary Recall of its Pipeline(TM) Embolization Device and Alligator(TM) Retrieval Device
Devices Product Recall
 HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 7 Apr 2014
New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia
Devices Monitoring
 HSMN NewsFeed - 4 Apr 2014
Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans
Devices Neurosurgery FDA
 HSMN NewsFeed - 2 Apr 2014
Luoxis Obtains CE Marking for RedoxSYS(TM) Diagnostic System
Diagnostics Regulatory
 HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 31 Mar 2014
Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Mar 2014
Flagler Hospital Upgrades to Masimo SET(R) Pulse Oximetry for Improved Patient Outcomes
Devices Monitoring
 HSMN NewsFeed - 6 Mar 2014
Boston Heart Enables Healthcare Providers to Better Identify Near-Term Risk of Heart Attack or Stroke with Launch of an Important Inflammation Marker, Myeloperoxidase (MPO)
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 3 Mar 2014
Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2014
In a Subanalysis, Eliquis(R) (apixaban) Reduced the Risk of Stroke and Demonstrated Fewer Major Bleeding Events versus Warfarin Consistently across Age Groups, Including Older Patients with Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Feb 2014
Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome
Devices Neurosurgery
 HSMN NewsFeed - 18 Feb 2014
Claret Medical Announces IDE Approval for U.S. Pivotal Trial of the Sentinel(TM) Cerebral Protection System
Devices Interventional FDA
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
stroke
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.